Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Anand Padmanabhan MD, PhD

Associate Professor

Institution: Medical College of Wisconsin
Department: Pathology
Division: Administration

Member of the Cancer Center


Publications

  • Intravenous immunoglobulin as an adjunct therapy in persisting heparin-induced thrombocytopenia. (Park BD, Kumar M, Nagalla S, De Simone N, Aster RH, Padmanabhan A, Sarode R, Rambally S) Transfus Apher Sci 2018 Aug;57(4):561-565 PMID: 30244713 09/25/2018    
  • Disease burden, complication rates, and health-care costs of heparin-induced thrombocytopenia in the USA: a population-based study. (Dhakal B, Kreuziger LB, Rein L, Kleman A, Fraser R, Aster RH, Hari P, Padmanabhan A) Lancet Haematol 2018 May;5(5):e220-e231 PMID: 29703336 04/29/2018       3 Citations
  • Cellular collection by apheresis. (Padmanabhan A) Transfusion 2018 02;58 Suppl 1:598-604 PMID: 29443409 02/15/2018       1 Citations
  • Normal plasma IgG inhibits HIT antibody-mediated platelet activation: implications for therapeutic plasma exchange. (Jones CG, Pechauer SM, Curtis BR, Bougie DW, Aster RH, Padmanabhan A) Blood 2018 02 08;131(6):703-706 PMID: 29259003 PMCID: PMC5805490 12/21/2017    
  • A Platelet Factor 4-Dependent Platelet Activation Assay Facilitates Early Detection of Pathogenic Heparin-Induced Thrombocytopenia Antibodies. (Jones CG, Pechauer SM, Curtis BR, Bougie DW, Irani MS, Dhakal B, Pierce B, Aster RH, Padmanabhan A) Chest 2017 10;152(4):e77-e80 PMID: 28991552 PMCID: PMC5812761 10/11/2017       3 Citations
  • IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia. (Padmanabhan A, Jones CG, Pechauer SM, Curtis BR, Bougie DW, Irani MS, Bryant BJ, Alperin JB, Deloughery TG, Mulvey KP, Dhakal B, Wen R, Wang D, Aster RH) Chest 2017 09;152(3):478-485 PMID: 28427966 PMCID: PMC5812774 04/22/2017       17 Citations
  • Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue. (Schwartz J, Padmanabhan A, Aqui N, Balogun RA, Connelly-Smith L, Delaney M, Dunbar NM, Witt V, Wu Y, Shaz BH) J Clin Apher 2016 Jun;31(3):149-62 PMID: 27322218 06/21/2016       257 Citations
  • A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis. (Padmanabhan A, Jones CG, Curtis BR, Bougie DW, Sullivan MJ, Peswani N, McFarland JG, Eastwood D, Wang D, Aster RH) Chest 2016 09;150(3):506-15 PMID: 26905366 PMCID: PMC5028397 02/26/2016       17 Citations
  • A modified PF4-dependent, CD62p expression assay selectively detects serotonin-releasing antibodies in patients suspected of HIT. (Padmanabhan A, Jones CG, Bougie DW, Curtis BR, McFarland JG, Wang D, Aster RH) Thromb Haemost 2015 Nov 25;114(6):1322-3 PMID: 26177881 PMCID: PMC4849413 07/17/2015       6 Citations
  • NHLBI state of the science symposium in therapeutic apheresis: Knowledge gaps and research opportunities in the area of hematology-oncology. (Karafin MS, Sachais BS, Connelly-Smith L, Field JJ, Linenberger ML, Padmanabhan A) J Clin Apher 2016 Feb;31(1):38-47 PMID: 25940408 05/06/2015       5 Citations
  • Why "R" HIT patients predisposed to thrombosis? (Padmanabhan A) Blood 2015 Apr 09;125(15):2319-20 PMID: 25858890 04/11/2015       2 Citations
  • Use of a dual lumen port for automated red cell exchange in adults with sickle cell disease. (Shrestha A, Jawa Z, Koch KL, Rankin AB, Xiang Q, Padmanabhan A, Karafin MS, Field JJ) J Clin Apher 2015 Dec;30(6):353-8 PMID: 25790325 03/20/2015       14 Citations
  • Critical role of CD4 T cells in PF4/heparin antibody production in mice. (Zheng Y, Yu M, Padmanabhan A, Aster RH, Yuan L, Wen R, Wang D) Blood 2015 Mar 12;125(11):1826-9 PMID: 25595736 PMCID: PMC4357587 01/18/2015       10 Citations
  • Spectra Optia granulocyte apheresis collections result in higher collection efficiency of viable, functional neutrophils in a randomized, crossover, multicenter trial. (Cancelas JA, Padmanabhan A, Le T, Ambruso DR, Rugg N, Worsham DN, Pinkard SL, Graminske S, Buck J, Goldberg J, Bill J) Transfusion 2015 Apr;55(4):748-55 PMID: 25382805 11/11/2014       5 Citations
  • Heparin-independent, PF4-dependent binding of HIT antibodies to platelets: implications for HIT pathogenesis. (Padmanabhan A, Jones CG, Bougie DW, Curtis BR, McFarland JG, Wang D, Aster RH) Blood 2015 Jan 01;125(1):155-61 PMID: 25342714 PMCID: PMC4281824 10/25/2014       31 Citations
  • Use of laboratory tests to guide initiation of autologous hematopoietic progenitor cell collection by apheresis: results from the multicenter hematopoietic progenitor cell collection by Apheresis Laboratory Trigger Survey. (Makar RS, Padmanabhan A, Kim HC, Anderson C, Sugrue MW, Linenberger M) Transfus Med Rev 2014 Oct;28(4):198-204 PMID: 25311468 10/15/2014       6 Citations
  • Development of a clinically significant ADAMTS13 inhibitor in a patient with hereditary thrombotic thrombocytopenic purpura. (Raval JS, Padmanabhan A, Kremer Hovinga JA, Kiss JE) Am J Hematol 2015 Jan;90(1):E22 PMID: 25219856 09/16/2014       7 Citations
  • Evaluation of the Spectra Optia apheresis system for mononuclear cell (MNC) collection in G-CSF mobilized and nonmobilized healthy donors: results of a multicenter study. (Karafin MS, Graminske S, Erickson P, Walters MC, Scott EP, Carter S, Padmanabhan A) J Clin Apher 2014 Oct;29(5):273-80 PMID: 24677347 03/29/2014    
  • B-cell tolerance regulates production of antibodies causing heparin-induced thrombocytopenia. (Zheng Y, Wang AW, Yu M, Padmanabhan A, Tourdot BE, Newman DK, White GC, Aster RH, Wen R, Wang D) Blood 2014 Feb 06;123(6):931-4 PMID: 24357731 PMCID: PMC3916881 12/21/2013       16 Citations
  • American society for apheresis guidelines support use of red cell exchange transfusion for severe malaria with high parasitemia. (Shaz BH, Schwartz J, Winters JL, Padmanabhan A, Balogun RA, Delaney M, Szczepiorkowski ZM, Williams ME, Wu Y, Linenberger ML) Clin Infect Dis 2014 Jan;58(2):302-3 PMID: 24092801 10/05/2013       9 Citations
  • Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. (Schwartz J, Winters JL, Padmanabhan A, Balogun RA, Delaney M, Linenberger ML, Szczepiorkowski ZM, Williams ME, Wu Y, Shaz BH) J Clin Apher 2013 Jul;28(3):145-284 PMID: 23868759 07/23/2013       392 Citations
  • Conversion to low transfusion-related acute lung injury (TRALI)-risk plasma significantly reduces TRALI. (Arinsburg SA, Skerrett DL, Karp JK, Ness PM, Jhang J, Padmanabhan A, Gibble J, Schwartz J, King KE, Cushing MM) Transfusion 2012 May;52(5):946-52 PMID: 22060800 11/09/2011       23 Citations
  • Transfusion requirements in obstetric patients with placenta accreta. (Stotler B, Padmanabhan A, Devine P, Wright J, Spitalnik SL, Schwartz J) Transfusion 2011 Dec;51(12):2627-33 PMID: 21658046 06/11/2011       41 Citations
  • Comparative outcome analysis of ABO-incompatible and positive crossmatch renal transplantation: a single-center experience. (Padmanabhan A, Ratner LE, Jhang JS, Duong JK, Markowitz GS, Vasilescu ER, Crew RJ, Schwartz J) Transplantation 2009 Jun 27;87(12):1889-96 PMID: 19543070 06/23/2009       12 Citations
  • Use of the haematopoietic progenitor cell parameter in optimizing timing of peripheral blood stem cell harvest. (Padmanabhan A, Reich-Slotky R, Jhang JS, Dael S, Crowder T, Colovai AI, Schwartz J) Vox Sang 2009 Aug;97(2):153-9 PMID: 19392781 04/28/2009       14 Citations
  • Transfusion therapy in postpartum hemorrhage. (Padmanabhan A, Schwartz J, Spitalnik SL) Semin Perinatol 2009 Apr;33(2):124-7 PMID: 19324242 03/28/2009       22 Citations
  • Last update: 01/16/2017
    jenkins-FCD Prod-300 626508253d14e4184314fb9f66322a03a5906796